| Q35087504 | Future treatments for diabetic neuropathy: clues from experimental neuropathy |
| Q37319721 | Gene therapy for the treatment of diabetic neuropathy |
| Q36446943 | Gene therapy for the treatment of sensory neuropathy |
| Q36601441 | Gene therapy for vascular disease |
| Q36274402 | Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells. |
| Q35064197 | Implications of diabetes mellitus in urology |
| Q45456081 | Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system |
| Q44593403 | Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice |
| Q46914176 | Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and biochemical evidence |
| Q45168373 | Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence |
| Q28084413 | Neurotrophins and Neuropathic Pain: Role in Pathobiology |
| Q35145450 | Neurotrophins and neurodegeneration. |
| Q34838448 | Oxidative stress and diabetic neuropathy: a new understanding of an old problem |
| Q34556841 | Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin |
| Q31139925 | Progressive multiple sclerosis: from pathogenic mechanisms to treatment. |
| Q45403886 | Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer |
| Q46903066 | Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations |
| Q40576520 | Role of neurotrophins in neuropathic pain |
| Q37536064 | Stem cell therapy for neuropathic pain treatment |
| Q37126431 | The influence of genetics on intracranial aneurysm formation and rupture: current knowledge and its possible impact on future treatment. |
| Q38106693 | The other bladder syndrome: underactive bladder. |
| Q26849274 | The role of neurotrophins in multiple sclerosis-pathological and clinical implications |
| Q36762639 | The therapeutic potential of gene transfer for the treatment of peripheral neuropathies |
| Q37464743 | Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials |
| Q92004130 | Underactive bladder: A review of the current treatment concepts |
| Q45889315 | Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy |